Pharmaceutical News and Articles

More Than 460 CDC Workers Reinstated After Layoffs

FRIDAY, June 13, 2025 More than 460 laid-off employees at the U.S. Centers for Disease Control and Prevention (CDC) are being rehired, officials said June 11.Th

FDA Approves Zusduri (mitomycin) for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59 at Increased Risk for RSV Disease

Accelerated Biological Aging Tied To Dementia, Stroke Risk

THURSDAY, June 12, 2025 A hallmark of accelerated aging appears to be linked to an increased risk of dementia and stroke, a new study says. Shorter telomere len

New Antibody Shot, Enflonsia, Could Help Protect Babies From RSV

THURSDAY, June 12, 2025 A newly approved shot could soon help protect babies from respiratory syncytial virus (RSV), the top cause of hospitalization in U.S. in

RFK Jr. Hires Autism Skeptic To Look Into CDC Autism Data

THURSDAY, June 12, 2025 A longtime vaccine critic hired by Health Secretary Robert F. Kennedy Jr. is reviewing safety data in an effort to revisit debunked clai

Talking Therapy Reduces Depression, Anxiety Symptoms in Stroke Survivors

For stroke survivors, talking therapy is associated with moderate reductions in depression and large reductions in anxiety symptoms, according to a study publis

Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance

For patients with metastatic melanoma, mitochondrial (MT) haplogroup T (HG-T) is associated with resistance to an anti-programmed cell death protein-1-based imm

RFK Jr. Installs Critics on Vaccine Recommendation Panel

THURSDAY, June 12, 2025 Days after ousting all 17 members of the panel that makes U.S. vaccine recommendations, Health Secretary Robert F. Kennedy Jr. has begun

Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials

For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent on average, which is lower than the